• 1
    Lehrer IR, Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 1999; 11:237.
  • 2
    Boman HG. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 1995; 13:6192.
  • 3
    Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998; 9:399414.
  • 4
    Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995; 374:15.
  • 5
    Cowland JB, Johnsen AH, Borregaard N. hCAP18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett 1995; 368:1736.
  • 6
    Agerberth B, Gunne H, Odeberg J, Kogner P, Boman HG, Gudmundsson GH. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci USA 1995; 92:1959.
  • 7
    Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP18 is expressed in epithelia of the human lung where it has broad anti-microbial activity at the airway surface. Proc Natl Acad Sci USA 1998; 95:95416.
  • 8
    Nilsson MF, Sandstedt B, Sørensen O, Weber G, Borregaard N, Ståhle-Bäckdahl M. The human cationic antibacterial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999; 67:25616.
  • 9
    Frohm M, Agerberth B, Ahangari G, Ståhle-Bäckdahl M, Lidén S, Wigzell H, Gudmundsson GH. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 272:1525863.
  • 10
    Larrick JW, Hirata M, Zheng H, Zhong J, Bolin D, Cavaillon J-M, Warren HS, Wright SC. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol 1998; 152:23140.
  • 11
    Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-α by blocking the binding of LPS to CD14+ cells. J Immunol 2001; 167:332938.
  • 12
    Rothe MJ, Nowak M, Kerdel FA. The mast cell in health and disease. J Am Acad Dermatol 1990; 23:61524.
  • 13
    Enerback L, Pipkorn U, Granelus G. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol 1986; 80:4451.
  • 14
    Godfrey HP, Ilardi C, Engber W, Graziano FM. Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 1984; 27:8526.
  • 15
    Gibson PG, Allen CJ, Yang JP, Wong BJO, Dolovich J, Denburg J, Hargreave FE. Epithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings. Am Rev Respir Dis 1993; 148:806.
  • 16
    Sawada J, Itakura A, Tanaka A, Furusaka T, Matsuda H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood 2000; 95:20528.
  • 17
    Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994; 153:371723.
  • 18
    Olsson N, Piek E, Ten Dijke P, Nilsson G. Human mast cell migration in response to members of the transforming growth factor-β family. J Leukoc Biol 2000; 67:3506.
  • 19
    Nilsson G, Johnell M, Hammer CH, Tiffany HL, Nilsson K, Metcalfe DD, Siegbahn A, Murphy PM. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 1996; 157:16938.
  • 20
    Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000; 192:106974.
  • 21
    Niyonsaba F, Someya A, Hirata M, Ogawa H, Nagaoka I. Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2 production from mast cells. Eur J Immunol 2001; 31:106675.DOI: 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.3.CO;2-R
  • 22
    Nagaoka I, Hirota S, Yomogida S, Ohwada A, Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm Res 2000; 49:739.DOI: 10.1007/s000110050561
  • 23
    Nagaoka I, Hirata M, Sugimoto K, Tsutsumi-Ishii Y, Someya A, Saionji K, Igari I. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J Leukoc Biol 1998; 64:84552.
  • 24
    Iwabuchi K, Nagaoka I, Someya A, Yamashita T. Isolation and characterization of the neutrophil-binding proteins for platelet-derived adherence-inhibiting factor. Blood 1993; 82:188490.
  • 25
    Klein C, Paul JI, Sauvé K et al. Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol 1998; 16:13347.
  • 26
    Munson PJ, Rodbard D. ligand. A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107:22039.
  • 27
    Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:43645.
  • 28
    Bals R, Weiner DJ, Moscioni AD, Meegalla RL, Wilson JM. Augmentation of innate host defense by expression of cathelicidin antimicrobial peptide. Infect Immun 1999; 67:60849.